Page last updated: 2024-10-25

clioquinol and Autosomal Dominant Juvenile Parkinson Disease

clioquinol has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 2 studies

Clioquinol: A potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. The oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.
5-chloro-7-iodoquinolin-8-ol : A monohydroxyquinoline that is quinolin-8-ol in which the hydrogens at positions 5 and 7 are replaced by chlorine and iodine, respectively. It has antibacterial and atifungal properties, and is used in creams for the treatment of skin infections. It has also been investigated as a chelator of copper and zinc ions for the possible treatment of Alzheimer's disease.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lei, P1
Ayton, S1
Appukuttan, AT1
Volitakis, I2
Adlard, PA2
Finkelstein, DI2
Bush, AI2
Billings, JL1
Hare, DJ1
Nurjono, M1
Cherny, RA1

Other Studies

2 other studies available for clioquinol and Autosomal Dominant Juvenile Parkinson Disease

ArticleYear
Clioquinol rescues Parkinsonism and dementia phenotypes of the tau knockout mouse.
    Neurobiology of disease, 2015, Volume: 81

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Clioquinol; Dementia; Disease Models, Animal; Dopami

2015
Effects of Neonatal Iron Feeding and Chronic Clioquinol Administration on the Parkinsonian Human A53T Transgenic Mouse.
    ACS chemical neuroscience, 2016, Mar-16, Volume: 7, Issue:3

    Topics: Animals; Animals, Newborn; Clioquinol; Disease Models, Animal; Humans; Iron; Iron Chelating Agents;

2016